Intravitreal injections with vascular endothelial growth factor inhibitors constitute the most prevalent ophthalmic procedure in developed countries. Historically, there has been steady growth in the number of treatments performed of this kind, and projection studies estimate further growth in such treatments in the future. We provide a practical approach to intravitreal injections and discuss important aspects relating to the setting, the patient, the procedure, and the information given to the patient.
Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach / Petri, A. -S.; Boysen, K.; Cehofski, L. J.; van Dijk, E. H. C.; Dysli, C.; Fuchs, J.; Mastropasqua, R.; Subhi, Y.. - In: OPHTHALMOLOGY AND THERAPY. - ISSN 2193-8245. - 9:1(2020), pp. 191-203. [10.1007/s40123-020-00230-4]
Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach
Mastropasqua R.Writing – Review & Editing
;
2020
Abstract
Intravitreal injections with vascular endothelial growth factor inhibitors constitute the most prevalent ophthalmic procedure in developed countries. Historically, there has been steady growth in the number of treatments performed of this kind, and projection studies estimate further growth in such treatments in the future. We provide a practical approach to intravitreal injections and discuss important aspects relating to the setting, the patient, the procedure, and the information given to the patient.
| File | Dimensione | Formato | |
|---|---|---|---|
|
s40123-020-00230-4.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
320.58 kB
Formato
Adobe PDF
|
320.58 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
